Guggenheim Maintains Buy on Humana, Raises Price Target to $269

Benzinga Newsdesk www.benzinga.com Positive 72.1%

Neg 0% Neu 0% Pos 72.1%

Guggenheim analyst Jason Cassorla maintains Humana (NYSE:HUM) with a Buy and raises the price target from $252 to $269.

Comments

No comments yet. Be the first!